Scholar

Kathryn A. Phillips

H-index: 42
Economics 44%
Biology 30%
kathrynp-phd.bsky.social
Many questions about Pfizer deal with Trump Administration to avoid tariffs. Why does the federal government need to become a drug marketer? Doesn’t it already do enough not very well? www.wsj.com/opinion/dona... via @WSJopinion
Opinion | America’s Pharmacist in Chief
The President becomes a drug marketer, while Pfizer gets a tariff break.
www.wsj.com
kathrynp-phd.bsky.social
Here's where behavioral economics and the great insights of Daniel Kahneman (who I learned so much from when I took his class at UC-Berkeley) could be useful....
robcaliff.bsky.social
An opinion about the need to better understand the framing and decision making that impacts so much of preventive public health--"habits" and inconveniences to prevent low probability, but high impact future events in return for some up front risk.

substack.com/@robcaliff27...
Interventions for Low-Probability Events
Recently, I have been struggling to understand why so few people have taken the updated COVID booster when the benefit-risk calculation seems so straightforward.
substack.com
kathrynp-phd.bsky.social
Nicely nuanced discussion about balancing risk/benefit. This struck me “COVID vaccine decision is qualitatively different than vaccines such as polio... because the vaccines prevent transmission. With COVID vaccination, the benefit is to the individual, with modest effects on transmission.”
kathrynp-phd.bsky.social
On the rare day that it's 85 degrees in San Francisco, one must eat soft serve on the Bay!
robcaliff.bsky.social
An opinion about the need to better understand the framing and decision making that impacts so much of preventive public health--"habits" and inconveniences to prevent low probability, but high impact future events in return for some up front risk.

substack.com/@robcaliff27...
Interventions for Low-Probability Events
Recently, I have been struggling to understand why so few people have taken the updated COVID booster when the benefit-risk calculation seems so straightforward.
substack.com
kathrynp-phd.bsky.social
Interesting book about my alma mater @UCBerkeley's evolution from early backlash against corporate collaborations to current exuberance for entrepreneurs and startups. iande.berkeley.edu/startupcampus
Startup Campus: How UC Berkeley Became an Unexpected Leader in Entrepreneurship and Startups | Innovation & Entrepreneurship
iande.berkeley.edu
kathrynp-phd.bsky.social
Sorry to hear that Drummond Rennie passed away. When he was @JAMA_current Deputy Editor based in SF, I benefited so much from his mentorship. He did not mince words in telling me when my work needed improvement - and indeed, he was right.
kathrynp-phd.bsky.social
The federal government’s $1B demand is designed for one purpose and one purpose only: to devastate @UCLA and its critical mission. Join me and #StandUpForUC to defend @uofcalifornia and support its life-saving work. www.universityofcalifornia.edu/get-involved...
Stand Up for UC
The federal government’s demand of $1 billion from UCLA puts the entire University of California system at risk. Stand with us to protect UC.
www.universityofcalifornia.edu

Reposted by: Kathryn A. Phillips

hadleyssmith.bsky.social
Looking forward to participating in this webinar to discuss our work on distributional cost-effectiveness analysis in genomic medicine, recently published in Value in Health www.sciencedirect.com/science/arti...
icer-review.bsky.social
The Health Economics Methods Advisory (HEMA) has a new website! hemamethods.org

HEMA was convened by leaders at 3 global HTA organizations: ICER, @nicecomms.bsky.social, and @cda-amc.bsky.social
to critically and independently examine and assess new methods and processes.
Health Economics Methods Advisory
hemamethods.org

References

Fields & subjects

Updated 1m